1. Home
  2. BFLY vs EVO Comparison

BFLY vs EVO Comparison

Compare BFLY & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Butterfly Network Inc.

BFLY

Butterfly Network Inc.

HOLD

Current Price

$3.96

Market Cap

929.6M

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.45

Market Cap

821.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFLY
EVO
Founded
2011
1993
Country
United States
Germany
Employees
190
4766
Industry
Medical Electronics
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
929.6M
821.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BFLY
EVO
Price
$3.96
$2.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$4.88
$7.00
AVG Volume (30 Days)
5.7M
115.5K
Earning Date
05-01-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.64
N/A
Revenue Next Year
$22.37
$7.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.32
$2.31
52 Week High
$5.03
$4.80

Technical Indicators

Market Signals
Indicator
BFLY
EVO
Relative Strength Index (RSI) 54.38 29.39
Support Level $3.59 N/A
Resistance Level $4.03 $3.78
Average True Range (ATR) 0.31 0.09
MACD 0.06 -0.07
Stochastic Oscillator 37.29 11.40

Price Performance

Historical Comparison
BFLY
EVO

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: